ProCE Banner Activity

Therapeutically Actionable Biomarkers in Lung Cancer: Clinical Applications for Nursing Practice

PDF
Download this treatment summary reference guide for a review of updates in targeted therapies for NSCLC.

Released: March 18, 2022

Expiration: March 17, 2023

No longer available for credit.

Share

Faculty

Beth Sandy

Beth Sandy, MSN, CRNP

Nurse Practitioner
Abramson Cancer Center
University of Pennsylvania
Philadelphia, Pennsylvania

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

Lilly

Merck Sharp & Dohme Corp.

Novartis Pharmaceuticals Corporation

Regeneron Pharmaceuticals, Inc.

Sanofi Genzyme

Faculty Disclosure

Primary Author

Beth Sandy, MSN, CRNP

Nurse Practitioner
Abramson Cancer Center
University of Pennsylvania
Philadelphia, Pennsylvania

Beth Sandy, MSN, CRNP, has disclosed that she has received consultant/advisor/speaker fees from Amgen, AstraZeneca, Janssen, Jazz, Merck, and Takeda.